PATENT CLAIM ANALYSIS

Application Number: 15962999
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "259000"]

Abstract:
Disclosed herein are methods, pharmaceutical combinations, or kits for the prevention or treatment of extrapyramidal syndromes, for example, dyskinesia, dystonia, akathisia, or drug-induced Parkinsonism, with the administration of a therapeutic effective amount of Trapidil, a derivative, a metabolite, a prodrug, an analog, or a pharmaceutically acceptable salt thereof.

Claim (Index 34):
The method of  claim 33 , wherein the movement disorder is manifested as a dyskinesia, dystonia, akathisia, bradykinesia, tremors, or akinesia.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 91.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14337037', '15310415', '15622265', '15898148', '15898143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7864928080942458
- 35 USC 102 Novelty (BERT): 0.5033012044719715
- Combined Prediction Score: 0.7581736477320185
- Mean Citation Score: 218.051026
- Max Citation Score: 232.42865
- Similarity Product: 162.28737442701757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test